![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 3-(3-fluorophenyl)-2-((1s)-1-(7h-purin-6-ylamino)propyl)chromen-4-one
2. Rp6530
1. 1639417-53-0
2. Rp6530
3. Tenalisib [inn]
4. 2261hh611h
5. (s)-2-(1-((7h-purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4h-chromen-4-one
6. 3-(3-fluorophenyl)-2-[(1s)-1-(7h-purin-6-ylamino)propyl]chromen-4-one
7. Rp-6530
8. 3-(3-fluorophenyl)-2-((1s)-1-((7h-purin-6-yl)amino)propyl)-4h-1-benzopyran-4-one
9. 4h-1-benzopyran-4-one, 3-(3-fluorophenyl)-2-((1s)-1-(9h-purin-6-ylamino)propyl)-
10. Tenalisib (rp6530)
11. 3-(3-fluorophenyl)-2-((1s)-1-(7h-purin-6-ylamino)propyl)chromen-4-one
12. Rp6530, Tenalisib
13. Tenalisib [who-dd]
14. Gtpl9907
15. Chembl4297584
16. Schembl16279460
17. Schembl21828463
18. Unii-2261hh611h
19. Bcp25998
20. Ex-a2699
21. Bdbm50512870
22. Nsc803014
23. Rp6530rp6530
24. S8672
25. Akos037645008
26. Ccg-268828
27. Cs-6375
28. Db15295
29. Nsc-803014
30. Rp 6530
31. As-56118
32. Hy-17645
33. A16799
34. C73162
35. A857570
36. Q27253617
37. (s)-2-(1-((9h-purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4h-chromen-4-one
38. 3-(3-fluorophenyl)-2-[(1s)-1-[(9h-purin-6-yl)amino]propyl]-4h-chromen-4-one
39. 1693773-94-2
Molecular Weight | 415.4 g/mol |
---|---|
Molecular Formula | C23H18FN5O2 |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 415.14445300 g/mol |
Monoisotopic Mass | 415.14445300 g/mol |
Topological Polar Surface Area | 92.8 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 704 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Phosphoinositide-3 Kinase Inhibitors
Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity. (See all compounds classified as Phosphoinositide-3 Kinase Inhibitors.)